The FDA has approved Journavx, a new non-opioid painkiller designed to treat moderate to severe acute pain. Unlike opioids, ...

A group of Senators has warned the FDA about an ad expected to air during Sunday’s big game that they believe misleads ...

Hims & Hers Health is set to have a commercial air during Super Bowl LIX. It’s already courting controversy, with calls to ...

Iterum Therapeutics (($ITRM)) has held its Q4 earnings call. Read on for the main highlights of the call. During Iterum Therapeutics’ latest ...

Drug industry calls out telehealth company Hims & Hers' Super Bowl ad touting its knock-off weight loss medications.

The recent FDA approvals of two treatments for molluscum contagiosum may represent a shift in how clinicians view this disease, according to a speaker at Masters of Pediatric Dermatology.In an ...

Q4 2024 Earnings Call Transcript February 7, 2025 Iterum Therapeutics plc beats earnings expectations. Reported EPS is $-0.12, expectations were $-0.24. Operator: Hello, everyone. And welcome to the ...

We recently compiled a list of the 12 Best Healthcare Stocks to Buy According to Analysts. In this article, we are going to ...

The La Center School District is the latest in Clark County to revise its policy on tobacco and nicotine products as they rapidly evolve beyond old-fashioned cigarettes.

In its second attempt, Takeda has secured FDA approval for Eohilia, which becomes the first and only oral therapy in the US for eosinophilic oesophagitis (EoE). The US regulator has cleared ...

Donald Trump’s second administration has advanced an avalanche of policy action and political pronouncements that have jolted ...

Compounded semaglutide is legal, but it's not regulated in the same way as medications like Ozempic and Wegovy.